+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07782684

Study of Gamma Delta T Cell Recovery and Its Impact After Unrelated Umbilical Cord Blood Transplant for Blood Disorders

Led by Anhui Provincial Hospital · Updated on 2026-08-24

100

Participants Needed

1

Research Sites

204 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the recovery patterns of gamma delta T cells after allogeneic umbilical cord blood transplantation UCBT, a treatment for blood cancers and other disorders. The study aims to understand how the reconstitution of these immune cells relates to important outcomes like graft-versus-host disease GVHD, relapse rates, transplant-related mortality, and overall survival. This observational study seeks to uncover new markers that could guide future immune therapies to improve patient prognosis. Participants in this study have undergone unrelated cord blood transplants. Researchers will collect blood samples over time to monitor the amount, proportion, and changes in major functional subsets of T cells using flow cytometry. The study focuses on describing the immune recovery process without administering new treatments, following all patients in a single cohort. Throughout the study, participants will have their immune cells and clinical outcomes closely observed and recorded. Key outcomes include the level of T cell recovery at one year, survival rates up to five years, relapse incidence, and occurrence of acute and chronic GVHD. This long-term monitoring will help link immune cell patterns to health outcomes after transplantation, with the study expected to continue until 2030.

CONDITIONS

Brief Title

Reconstruction Kinetics of γδ T Cells After Unrelated Cord Blood Transplantation

Research Team

X

Xiao yu Zhu, ph.D

X

Xing chi Chen

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here